Drug Profile
OGT 2378
Latest Information Update: 22 Jun 2007
Price :
$50
*
At a glance
- Originator UCB
- Class Antineoplastics; Imino sugars; Piperidines
- Mechanism of Action Glucosylceramide synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Malignant melanoma